Mar. 19 at 2:56 PM
$GANX : Fix the Protein, Fix the Disease 🧬
Gain Therapeutics develops small molecule drugs that restore misfolded proteins, targeting the root cause of diseases like Parkinson’s instead of just treating symptoms.
Recent developments:
🥇 March 12: Update highlighting regulatory progress with the FDA and continued advancement of their lead Parkinson’s program
🥈 March 18: Presentation of interim Phase 1b data at a major conference, first real look at how the drug performs in patients
Catalysts:
🔹 Clinical data readouts (the big one)
🔹 Biomarker results showing real biological impact
🔹 Potential partnerships if the science hits
🔹 Pipeline expansion into other major diseases
With business development picking up, a massive neurodegenerative market in play, and a fresh
$7 price target from H.C. Wainwright, GANX is starting to look like one of those early setups that get harder to ignore!
Communicated Disclaimer: https://chartingdaily.com/structural-health
Sector peers:
$VRTX $ALNY $SRPT $NBIX
